ELITE PHARMACEUTICALS INC /NV/ reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Northvale, NJ
SEC filing record 1 source field available
Fiscal year end
31 March
ELITE PHARMACEUTICALS INC /NV/ has filed 1,215 SEC EDGAR filings since 30 Jan 1998

SEC filing history

Showing 101-125 of 753 matching filings.

Per page
25
Current page
5
10-Q File 001-15697

10-Q filing

Filing date
15 Aug 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Jul 2022
Reporting date
16 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-15697

10-K filing

Filing date
29 Jun 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
03 Jun 2022
Reporting date
16 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-15697

10-Q filing

Filing date
14 Feb 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
10-Q File 001-15697

10-Q filing

Filing date
15 Nov 2021
Reporting date
30 Sep 2021
Next action
Verify source filing
10-Q File 001-15697

10-Q filing

Filing date
16 Aug 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Jul 2021
Reporting date
17 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Jul 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Jul 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Jul 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-15697

10-K/A filing

Filing date
22 Jun 2021
Reporting date
31 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

CURRENT REPORT

Filing date
14 Jun 2021
Reporting date
14 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-15697

ANNUAL REPORT

Filing date
14 Jun 2021
Reporting date
31 Mar 2021
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .